Related Experiment Video
Updated: Aug 30, 2025
The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
A Ferroptosis-Related Gene Signature for Predicting Survival and Immunotherapy Effect in Renal Cancer
Liang Tong1, Zhao-Fa Yin1, Liang Peng1
1Department of Urology, Loudi Central Hospital of Hunan Province, Loudi, China.
Background:
Most recently, no efficient prognostic indictor is present for kidney cancer. Thus, we aimed to build and validate a new prognostic gene signature for renal cancer patients using the Cancer Genomic Atlas (TCGA).
Methods:
A "time-dependent receiver operating characteristic (tROC)" curve was generated, and a log-rank test was performed to assess the performance of the biomarker in training and validation. A "ferroptosis-related gene signature" was developed. In different training and validations sets, tROC and log-rank test were used to validate the biomarker's performance.
Results:
In the training set with a P value less than 0.01 and the validation set, the "gene signature" was significantly correlated with survival. Eventually, it was found that the ferroptosis-related gene signature was directly correlated with immune score and the score of tumor mutation, suggesting its role in predicting response to immunotherapy.
Conclusion:
We developed and validated a "ferroptosis-related gene signature" that can be sued for patients with kidney cancer. It can also assist in facilitating the plan for treatment and risk stratification.
